| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 7.84B | — |
| Operating expense | — | — |
| Net income | 1.10B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, B6E.F returned +57.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +32.5% |
| 1 year | +57.5% |
| 5 years | +132.5% |
| 10 years | +306.0% |
| All-time high | €43.54 (Jul 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in B6E.F would be worth today ›No. Swedish Orphan Biovitrum AB (publ) has not paid a dividend in the past 12 months.
Swedish Orphan Biovitrum AB (publ) is part of the Healthcare sector.
Swedish Orphan Biovitrum AB (publ) has a market cap of 14.21B EUR, based on the latest quote.
Swedish Orphan Biovitrum AB (publ) is scheduled to report earnings on Oct 27, 2026.
